Cosmos Health Inc. (COSM)
- Previous Close
0.4308 - Open
0.4240 - Bid 0.3010 x 200
- Ask 0.5374 x 200
- Day's Range
0.4100 - 0.4352 - 52 Week Range
0.2800 - 1.5800 - Volume
253,436 - Avg. Volume
404,933 - Market Cap (intraday)
11.46M - Beta (5Y Monthly) 4.30
- PE Ratio (TTM)
-- - EPS (TTM)
-1.1700 - Earnings Date Apr 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names. Other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag to promote peaceful sleep; Otikon ear drops, which is a Class II medical device in the form of ear drops; and Bio-bebe, an organic infant care and nutrition brand. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies, and independent specialty distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
www.cosmosholdingsinc.com149
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: COSM
View MorePerformance Overview: COSM
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: COSM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: COSM
View MoreValuation Measures
Market Cap
11.46M
Enterprise Value
22.94M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.15
Price/Book (mrq)
0.47
Enterprise Value/Revenue
0.42
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-29.73%
Return on Assets (ttm)
-15.85%
Return on Equity (ttm)
-53.43%
Revenue (ttm)
54.43M
Net Income Avi to Common (ttm)
-22.38M
Diluted EPS (ttm)
-1.1700
Balance Sheet and Cash Flow
Total Cash (mrq)
336.25k
Total Debt/Equity (mrq)
48.18%
Levered Free Cash Flow (ttm)
-649.54k